At LOWENCO, we believe in a solid and progressive corporate structure. We are confident that the collective healthcare expertise of our two owners, Impilo and SHS Capital, makes them the perfect partners to elevate LOWENCO to new heights of achievement. We aim to involve quality partnerships in our business, contributing to our ability to continue creating the best conditions for delivering temperature-controlled storage, ultra-low temperature freezers, and refrigerated units to the pharma- and biotech industries. Read more about our ownership and our Board of Directors below.
Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies active in pharmaceuticals, medical technology, healthcare services, and other health-related areas. Impilo strives to increasing the value of its investments through long-term active ownerships. The company has a well-diversified portfolio of investments and has raised more than SEK 9 billion in capital from leading Nordic and international investors since its beginning in 2017. The acquisition of LOWENCO A/S marks Impilo’s fourth investment in Denmark together with Ferrosan Medical Devices, Scantox, and tandlægen.dk. If you are curious to learn more about Impilo, you can find them at www.impilo.se.
SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. “Building European Healthcare Champions” is the investment philosophy according to which SHS finances and develops portfolio companies. The German investor takes both minority and majority stakes. The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity or equity-like investment of the AIF is up to € 40 million. Volumes in excess of this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI. SHS is currently investing from its sixth fund, which was launched in 2022 and has a volume of ca. € 250 million.
Learn more at www.shs-capital.eu.
Founded in 2013 and headquartered in Vamdrup, Denmark, LOWENCO A/S is a leading manufacturer of ultra-low temperature (“ULT”) storage solutions for the pharma- and biotech industries. The company serves a growing global customer base and its unique, highly energy-efficient, and sustainable ULT storage solutions, developed under the brand names LSSU and CON20, offer superior quality and technical performance, and a lower cost of ownership. LOWENCO follows GMP guidelines and has a steadily increasing R&D pipeline. You can learn much more at www.lowenco.com.